A phase I pharmacodynamic trial of bortezomib in combination with doxorubicin in patients with advanced cancer

被引：0
|
作者：
Noelle K. LoConte
James P. Thomas
Dona Alberti
Jennifer Heideman
Kimberly Binger
Rebecca Marnocha
Kyle Utecht
Peter Geiger
Jens Eickhoff
George Wilding
Jill Kolesar
机构：
[1] University of Wisconsin Paul P. Carbone Comprehensive Cancer Center,
[2] The Ohio State University Comprehensive Cancer Center,undefined
[3] University of Wisconsin School of Pharmacy,undefined
来源：
Cancer Chemotherapy and Pharmacology | 2008年 / 63卷
关键词：
Bortezomib; Doxorubicin; Ubiquitination; Proteasome inhibition;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
页码：109 / 115
页数：6
相关论文
共 50 条
  • [41] Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group
    Ciombor, Kristen K.
    Feng, Yang
    Benson, Al Bowen, III
    Su, Yingjun
    Horton, Linda
    Short, Sarah P.
    Kauh, John Sae Wook
    Staley, Charles
    Mulcahy, Mary
    Powell, Mark
    Amiri, Katayoun I.
    Richmond, Ann
    Berlin, Jordan
    INVESTIGATIONAL NEW DRUGS, 2014, 32 (05) : 1017 - 1027
  • [42] Phase II trial of bortezomib plus doxorubicin in hepatocellular carcinoma (E6202): a trial of the Eastern Cooperative Oncology Group
    Kristen K. Ciombor
    Yang Feng
    Al Bowen Benson
    Yingjun Su
    Linda Horton
    Sarah P. Short
    John Sae Wook Kauh
    Charles Staley
    Mary Mulcahy
    Mark Powell
    Katayoun I. Amiri
    Ann Richmond
    Jordan Berlin
    Investigational New Drugs, 2014, 32 : 1017 - 1027
  • [43] A phase I study of bortezomib in combination with doxorubicin and intermediate-dose dexamethasone (iPAD therapy) for relapsed or refractory multiple myeloma
    Yasushi Takamatsu
    Kazutaka Sunami
    Hiroyuki Hata
    Koji Nagafuji
    Ilseung Choi
    Masakazu Higuchi
    Kimiharu Uozumi
    Yasufumi Masaki
    Kazuo Tamura
    International Journal of Hematology, 2010, 92 : 503 - 509
  • [44] Phase 2 Trial of Bortezomib in Combination With Rituximab Plus Hyperfractionated Cyclophosphamide, Vincristine, Doxorubicin, and Dexamethasone Alternating With Bortezomib, Rituximab, Methotrexate, and Cytarabine for Untreated Mantle Cell Lymphoma
    Romaguera, Jorge E.
    Wang, Michael
    Feng, Lei
    Fayad, Luis E.
    Hagemeister, Frederick
    McLaughlin, Peter
    Rodriguez, M. Alma
    Fanale, Michelle
    Orlowski, Robert
    Kwak, Larry W.
    Neelapu, Sattva
    Oki, Yasuhiro
    Pro, Barbara
    Younes, Anas
    Samaniego, Felipe
    Fowler, Nathan
    Hartig, Kimberly
    Valentinetti, Marisa
    Smith, Judy
    Ford, Peggy
    Naig, Adam
    Medeiros, L. Jeffrey
    Kantarjian, Hagop M.
    Goy, Andre
    CANCER, 2018, 124 (12) : 2561 - 2569
  • [45] A phase I/II trial of docetaxel and oxaliplatin in patients with advanced gastric cancer
    Kim, Kyoung Ha
    Park, Young Suk
    Chang, Myung Hee
    Kim, Hyo Song
    Jun, Hyun Jung
    Uhm, Jieun
    Yi, Seong Yoon
    Lim, Do Hyoung
    Ji, Sang Hoon
    Park, Min Jae
    Lee, Jeeyun
    Park, Se Hoon
    Park, Joon Oh
    Lim, Ho Yeong
    Kang, Won Ki
    CANCER CHEMOTHERAPY AND PHARMACOLOGY, 2009, 64 (02) : 347 - 353
  • [46] Phase 1 Trial of Gemcitabine With Bortezomib in Elderly Patients With Advanced Solid Tumors
    Bommakanti, Satya V.
    Dudek, Arkadiusz Z.
    Khatri, Amit
    Kirstein, Mark N.
    Gada, Purvi D.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2011, 34 (06): : 597 - 602
  • [47] Efficacy and toxicity of vinorelbine with doxorubicin/cyclophosphamide combination chemotherapy in a phase I-II study for advanced or recurrent breast cancer patients.
    Saeki T.
    Takashima S.
    Ogita M.
    Tabei T.
    Adachi I.
    Tamura K.
    Takatsuka Y.
    Kanda K.
    Breast Cancer, 2006, 13 (2) : 159 - 165
  • [48] Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study
    Awada, A.
    Albanell, J.
    Canney, P. A.
    Dirix, L. Y.
    Gil, T.
    Cardoso, F.
    Gascon, P.
    Piccart, M. J.
    Baselga, J.
    BRITISH JOURNAL OF CANCER, 2008, 98 (09) : 1500 - 1507
  • [49] Bortezomib/docetaxel combination therapy in patients with anthracycline-pretreated advanced/metastatic breast cancer: a phase I/II dose-escalation study
    A Awada
    J Albanell
    P A Canney
    L Y Dirix
    T Gil
    F Cardoso
    P Gascon
    M J Piccart
    J Baselga
    British Journal of Cancer, 2008, 98 : 1500 - 1507
  • [50] A phase I study of bortezomib plus irinotecan in patients with advanced solid tumors
    Ryan, David R.
    O'Neil, Bell H.
    Supko, Jeffrey G.
    Lima, Carlo M. Rocha
    Dees, E. Claire
    Appleman, Leonard J.
    Clark, Jeffrey
    Fidias, Phinos
    Orlowski, Robert Z.
    Kashala, Oscar
    Eder, Joseph R.
    Cusack, James C., Jr.
    CANCER, 2006, 107 (11) : 2688 - 2697
12345